Talk to the Institute
Published mark

Opus Genetics, Inc.

NASDAQ: IRD. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:8dcbffcd-94f9-4108-b9f8-f0174a603232
SEC CIK
0001228627
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
Newest evidence
Mar 23, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Not published
Chair
Not published
Independent
5 / 55 directors published
Published claims
242 distinct sources
Evidence records
50 pinned
Source conflicts
0None open

Built from 2 distinct sources and 5 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Joseph Schachle executive of Opus Genetics, Inc., effective 2026-03-23.

EffectiveEffective Mar 23, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Operating OfficerJoseph SchachleMar 2026currentSource reportedE3
Chief Financial OfficerRobert GagnonMar 2026currentSource reportedE4

Board of directors

Evidence

5 directors published. 5 of 5 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Cam GallagherIndependent2020Compensation, chairCompensation · Chair; Nominating and GovernanceNominating and GovernanceSource reportedE2
David P. BennettIndependent2024None publishedSource reportedE2
Richard RodgersIndependent2020Audit, chairAudit · ChairSource reportedE2
Sean AinsworthIndependent2020AuditAudit; CompensationCompensationSource reportedE2
Susan K. BentonIndependent2020CompensationCompensation; Nominating and GovernanceNominating and GovernanceSource reportedE2
Dr. Adrienne GravesIndependence not publishedNot publishedNominating and GovernanceSource reportedE5
Dr. James S. ManusoIndependence not publishedNot publishedAuditNominating and Governance, chairSource reportedE5

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditRichard RodgersRichard Rodgers, Dr. James S. Manuso, Sean AinsworthNot described in the published record
Audit · ChairNot publishedRichard RodgersNot described in the published record
Audit; CompensationNot publishedSean AinsworthNot described in the published record
CompensationCam GallagherCam Gallagher, Sean Ainsworth, Susan K. BentonNot described in the published record
Compensation · Chair; Nominating and GovernanceNot publishedCam GallagherNot described in the published record
Compensation; Nominating and GovernanceNot publishedSusan K. BentonNot described in the published record
Nominating and GovernanceDr. James S. ManusoDr. James S. Manuso, Cam Gallagher, Dr. Adrienne Graves, Susan K. BentonNot described in the published record
Committee AppointmentRichard Rodgers: chair, Audit
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:13
Committee AppointmentDr. James S. Manuso: member, Audit
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:14
Committee AppointmentSean Ainsworth: member, Audit
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:15
Committee RecordCompensation: Chair Cam Gallagher; Members Cam Gallagher (Chair); Sean Ainsworth; Susan K. Benton
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_record:16
Committee AppointmentCam Gallagher: chair, Compensation
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:17
Committee AppointmentSean Ainsworth: member, Compensation
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:18
Committee AppointmentSusan K. Benton: member, Compensation
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:19
Committee AppointmentDr. James S. Manuso: chair, Nominating and Governance
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:21
Committee AppointmentCam Gallagher: member, Nominating and Governance
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:22
Committee AppointmentDr. Adrienne Graves: member, Nominating and Governance
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:23
Committee AppointmentSusan K. Benton: member, Nominating and Governance
Source reportedE5
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:committee_appointment:24

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingIRD (NASDAQ)
Source reportedE1
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:security_listing:25
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameOpus Genetics, Inc.
Source reportedE1
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:8dcbffcd-94f9-4108-b9f8-f0174a603232:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
5 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    Opus Genetics, Inc. DEF 14A 2026-03-23
    sec proxy. Published Mar 23, 2026. Retrieved Apr 25, 2026. Cited by 5 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    IRD DEF 14A executive officers
    sec filing. Published Mar 23, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    IRD DEF 14A executive officers
    sec filing. Published Mar 23, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    Audit
    board_seats. board seats. Cited by 13 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026
  • Joseph Schachle executive of Opus Genetics, Inc., effective 2026-03-23.
  • Robert Gagnon executive of Opus Genetics, Inc., effective 2026-03-23.
  • David P. Bennett seat on Opus Genetics, Inc., effective 2024-01-01.
  • Cam Gallagher seat on Opus Genetics, Inc., effective 2020-01-01.
  • Richard Rodgers seat on Opus Genetics, Inc., effective 2020-01-01.
  • Sean Ainsworth seat on Opus Genetics, Inc., effective 2020-01-01.
  • Susan K. Benton seat on Opus Genetics, Inc., effective 2020-01-01.
  • Audit · Chair committee of Opus Genetics, Inc., effective 2020-01-01.
  • Richard Rodgers member of Audit · Chair, effective 2020-01-01.
  • Audit; Compensation committee of Opus Genetics, Inc., effective 2020-01-01.
  • Sean Ainsworth member of Audit; Compensation, effective 2020-01-01.
  • Compensation · Chair; Nominating and Governance committee of Opus Genetics, Inc., effective 2020-01-01.
  • Cam Gallagher member of Compensation · Chair; Nominating and Governance, effective 2020-01-01.
  • Compensation; Nominating and Governance committee of Opus Genetics, Inc., effective 2020-01-01.
  • Susan K. Benton member of Compensation; Nominating and Governance, effective 2020-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:8dcbffcd-94f9-4108-b9f8-f0174a603232, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/opus-genetics-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership2
  4. Board7
  5. Committees7
  6. Control and voting0
  7. Authority to act3
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people9
  17. Subject and corrections6
  18. Evidence5
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:8dcbffcd-94f9-4108-b9f8-f0174a603232
  • Cite this recordOpus Genetics, Inc.
  • Copy canonical URLregistry.alpha.ac/companies/opus-genetics-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Opus Genetics, Inc.Company
  • Joseph SchachlePerson
  • Robert GagnonPerson
  • Cam GallagherPerson
  • David P. BennettPerson
  • Richard RodgersPerson
  • Sean AinsworthPerson
  • Susan K. BentonPerson
  • Dr. Adrienne GravesPerson
  • Dr. James S. ManusoPerson
  • Sections
    OverviewOpus Genetics, Inc.
  • MonitoringOpus Genetics, Inc.
  • LeadershipOpus Genetics, Inc.
  • BoardOpus Genetics, Inc.
  • CommitteesOpus Genetics, Inc.
  • Control and votingOpus Genetics, Inc.
  • Authority to actOpus Genetics, Inc.
  • FinancialsOpus Genetics, Inc.
  • GovernanceOpus Genetics, Inc.
  • RiskOpus Genetics, Inc.
  • AI oversightOpus Genetics, Inc.
  • LegalOpus Genetics, Inc.
  • CompensationOpus Genetics, Inc.
  • Other published claimsOpus Genetics, Inc.
  • Coverage gapsOpus Genetics, Inc.
  • Linked peopleOpus Genetics, Inc.
  • Subject and correctionsOpus Genetics, Inc.
  • EvidenceOpus Genetics, Inc.
  • Version historyOpus Genetics, Inc.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.